INTRODUCTION
Intermittent acute porphyria (IAP)' is a genetic disorder of heme and porphyrin biosynthesis. It is inherited by excessive excretion of the porplhyrin precursors, 8 -aminolevulinic acid (ALA) andcl porphobilinogen (PBG). On the basis of clinical features alnd a unique pattern of excessive excretion of porphyrins and porphyrin precursors, IAP has been distinguished from two related genetic hepatic porphyrias, variegate porphyria and hereditary coproporphyria. In all three of these porphyrias the liver is the primary site of overproduction of porphyrin precursors as a consequence of increased activity of 8-aminolevulinic acid synthetase (ALA-synthetase) (1) (2) (3) (4) (5) (6) (7) (8) , the first and rate-limiting enzyme in heme biosynthesis (9) (10) (11) . TAP is also associated with (lecreased hepatic uroporphyrinogen I synthetase (URO-Isynthetase) activity in contrast to variegate porphyria (7, 12) . URO-I-synthetase catalyzes the conversion of PBG to the tetrapyrrole uroporphvriniogeni (13) . A partial defect in heme synthesis at this site in IAP is therefore entirely consistent with the excessive excretioni of ALA and PBG out of proportion to other intermediates in the heme biosynthetic pathway. Moreover, to the extent that heme functions as a repressor ALA-synthetase (7, 10, 14-16) a primary partial defect in heme synthesis could result in a secondary. reciprocal induiction of ALA-synthetase.
All mammalian cells may be presumiied to have the enzymes necessary for heme biosynthesis. Therefore, if a decrease in URO-I-synthetase characterizes IAP, a relative decrease in this enzyme might be expected in tissues other than liver. Although Heilmeyer and Clotten observed a decreased hepatic production of porphyrins from ALA in a patient with IAP, they did not report such a defect in red cells (17) . However Chromatography. Thin-layer chromatography of the methyl esters of the enzymatically generated porphyrins was performed by the method of Doss (21, 22) . For these experiments a 20-fold increase in the volume of the reactants was used. At the end of the assay the incubation mixture was rapidly frozen and lyophilized to dryness, and the porphyrins were esterified in methanol-sulfuric acid (95: 5 v: v) for 12 hr at room temperature, before being extracted with chloroform. After flash evaporation, the porphyrin esters were taken up in a small volume of chloroform and streaked on cleaned silica gel H plates (Riedel-DeHaen AG, Seelze, Hannover, Germany). The plates were first developed in petroleum ether: diethyl ether (4: 1) to remove lipids and then in chloroform: benzene: methanol (85: 13.5: 1.5). Esterified hemin remained at the baseline while the porphyrins with from eight to two methylated carboxyl groups were clearly separated with increasing R,'s as the number of carboxyl groups decreased. Porphyrins were observed under a fluorescent lamp and further identified spectrophotometrically after chloroform elution of the porphyrin bands from silica gel using a millimolar extinction coefficient of 216 at 405.5 nM.
Partial purificatioit of URO-I-synthetase from red cells.
2 ml of freeze-thawed red cells were diluted to 4 ml with cold distilled water and heated for 15 min at 650C. After centrifugation at 2500 g X 10 min, 0.5 ml of the supernatant was passed through a Sephadex G-25 medium column (0.5 X 5 cm) and the enzyme fraction collected. Hemoglobin was then removed by the method of Hennessey, Waltersdorph, Huennekens, and Gabrio (23, 24) . Columns of DEAE-cellulose (Whatman DE-52, 0.5 X 2 cm) were equilibrated with 0.003 M phosphate buffer, pH 7.4 before adding the enzyme solution and were then washed with 15 ml of the same phosphate buffer. Resin was removed from the columns and the enzyme desorbed by repeated washings with 0.134 M phosphate buffer, pH 7.4. The washings were centrifuged at 5000 g x 10 min and the supernatant assayed for URO-I-synthetase activity. These procedures resulted in a 20-fold increase in specific activity and 80-85% recovery of total activity.
Porphyrins in urine and stool were quantitated fluorometrically after solvent phase partition (19) . Urinary porphyrin precursors were determined spectrophotometrically (25) .
Statistical methods of Ostle were used (26) . Saurces of drugs antd chemicals. PBG was synthesized (27) by Dr. G. Kohan and purchased from Protex Research and Development, Registered, Montreal, Canada, and was recrystallized from hydrochloric acid just before use. Purity was verified by UV absorption, reaction with Ehrlich's reagent, and melting point (28) . Porphyrins and their methyl esters were purchased from Dr. T. K. With, Copenhagen, Denmark. Other chemicals and reagents were purchased from J. T. Baker Chemical Co., Phillipsburg, N. J., or Sigma Chemical Co., St. Louis, Mo.
RESULTS
Validation of URO-I-synthetase assay. Several studies were done to validate the method of determining URO-I-synthetase activity. To remove small potentially fluorescing molecules, the hemolysates were passed over Sephadex G-25 columns (see Methods). All of the enzyme activity was recovered with the same specific activity and fluorescence excitation spectrum as the crude hemolysate. Isolated leukocytes-which had been freeze-thawed three times and diluted 1: 60 had no detectable URO-Jsynthetase activity. PBG conversion to uroporphyrinogen III is catalyzed by both heat stable URO-I-synthetase and heat labile uroporphyrinogen III cosynthetase (13, (29) (30) (31) . However, the cosynthetase is normally present in excess so that URO-I-synthetase is rate limiting (30) . When the hemolysates were heated at 65°C for Table I .
Kinetic characteristics of partialy purified URO-Isynthetase. The apparent Km of URO-I-synthetase was 6 X 10' M in the crude hemolysates from both nonporphyric subjects and patients with IAP, although the specific activity was reduced by about 50% in IAP patients. Similar results were obtained after 20-fold purification of the enzyme. A Lineweaver-Burke plot of one such experiment is depicted in Fig. 2 . The apparent Km was 6 X 10' M for both a nonporphyric subject and a /PBG (107M) FIGuRE 2 Lineweaver-Burke plot of red cell URO-I-synthetase partially purified 20-fold from a patient with intermittent acute porphyria (upper line) and a nonporphyric subject (lower line). The apparent Km value is 6 X 10-M for each plot. (7, 12) . The source of excessive excretion of porphyrin precursors in IAP is primarily hepatic where deficient URO-I-synthetase is associated with a marked increase in activity of the first and rate-controlling enzyme in the heme biosynthetic pathway, ALA-synthetase. Taking into consideration the function of heme as a negative feedback regulator of ALA-svnthetase, we have postulated that a primary partial defect in heme synthesis at the level of URO-T-synthetase might result in secondary derepression of hepatic ALA-svnthetase and overproduction of the porphyrin precursors ALA and PBG proximal to the site of the partial block. That this mechanism is plausible is supported by the recent demonstration that experimentally produced partial defects in heme synthesis in cultured hepatocytes results in increased ALA-synthetase activity and increased ALA-svnthetase induction by 2-allyl-2-isopropylacetamide (37). Although this speculative mechanism is attractive, other possibilities exist (1, 7, 12, 34) .
Defective URO-I-synthetase does not necessarily imply impaired hepatic heme synthesis since the Km of URO-I-synthetase is probably higher than the normal concentration of PBG in the liver. This is supported bthe observations that PBG is not detectable in normal liver using a method which can detect about 10' Ai PBG and Km of URO-T-svnthetase purified from bovine liver has been reported to be 5 X 10' M (38 (30, 40, 41 (34, 43) . Our observations raise the possibility that red cell URO-1-synthetase assay may be a more sensitive and specific indicator of the heterozvgous state than quantitation of urinary ALA and PBG during the latent stage of TAP. However, sampling of larger populations of porphyrics and nonporphyrics wvill be required to establish more firmly the level and specificitv of deficient URO-1-svnthetase in TAP.
The mechanism responsible for decreased URO-T-synthetase activity is not known. It does not appear to result solely from excessive ALA-synthetase activity since URO-I-synthetase activity is not diminished by induction of ALA-svnthetase in rats treated with 2-allyl-2-isopropylacetamide or in mice treated with griseofulvin (7, 12) . Furthermore, URO-I-synthetase activitv is not inhibited by 10' M PBG in vitro. Mixing experiments with crude and 20-fold partially purified URO-T-synthetase in which equal amounts of TAP and nonporphyric enzyme were assayed resulted in an additive yield. In addition, the putative inhibitor was not destroyed by heating at 65°C for 15 min. However, these observations do not exclude a tightly bound, heat stable inhibitor nor do they exclude other as yet undefined xnechanisms whereby URO-I-synthetase activity could be secondarily diminished.
Alternatively diminished URO-I-synthetase activity with a normal apparent K. could reflect a primary defect in IAP. This could result from decreased amount of enzyme or a structural alteration resulting in decreased catalytic activity.
The relationship between suggested derangement in steroid metabolism in IAP (44) and decreased URO-Isynthetase activity remains to be investigated as does the relationship of enzymatic aberrations in heme synthesis to the multiple clinical and chemical abnormalities observed in IAP and other hepatic porphyrias (8, 33, 45, 46) .
